CCCC CIK: 1662579

C4 Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−87.0
FY22:
−106
FY23:
−107
FY24:
−65.2
FY25:
−98.7
Change from FY21 to FY25
millions USD
FY21:
−189
FY22:
58.4
FY23:
158
FY24:
−51.3
FY25:
−8.60
Change from FY21 to FY25
millions USD
FY21:
171
FY22:
1.15
FY23:
45.5
FY24:
45.3
FY25:
126
millions USD
FY21:
−105
FY22:
−46.4
FY23:
97.0
FY24:
−71.1
FY25:
19.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−88.2
FY22:
−111
FY23:
−109
FY24:
−65.3
FY25:
−99.3

All amounts in millions USD Data source:SEC EDGAR